Literature DB >> 16917844

Evaluation of hydroperoxides in common pharmaceutical excipients.

Walter R Wasylaschuk1, Paul A Harmon, Gabriella Wagner, Amy B Harman, Allen C Templeton, Hui Xu, Robert A Reed.   

Abstract

While the physical properties of pharmaceutical excipients have been well characterized, impurities that may influence the chemical stability of formulated drug product have not been well studied. In this work, the hydroperoxide (HPO) impurity levels of common pharmaceutical excipients are measured and presented for both soluble and insoluble excipients. Povidone, polysorbate 80 (PS80), polyethylene glycol (PEG) 400, and hydroxypropyl cellulose (HPC) were found to contain substantial concentrations of HPOs with significant lot-to-lot and manufacturer-to-manufacturer variation. Much lower HPO levels were found in the common fillers, like microcrystalline cellulose and lactose, and in high molecular weight PEG, medium chain glyceride (MCG), and poloxamer. The findings are discussed within the context of HPO-mediated oxidation and formulating drug substance sensitive to oxidation. Of the four excipients with substantial HPO levels, povidone, PEG 400, and HPC contain a mixture of hydrogen peroxide and organic HPOs while PS80 contains predominantly organic HPOs. The implications of these findings are discussed with respect to the known manufacturing processes and chemistry of HPO reactivity and degradation kinetics. Defining critical HPO limits for excipients should be driven by the chemistry of a specific drug substance or product and can only be defined within this context. (c) 2006 Wiley-Liss, Inc. and the American Pharmacists Association.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16917844     DOI: 10.1002/jps.20726

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  27 in total

Review 1.  Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility.

Authors:  Yongmei Wu; Jaquan Levons; Ajit S Narang; Krishnaswamy Raghavan; Venkatramana M Rao
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

Review 2.  Impact of excipient interactions on solid dosage form stability.

Authors:  Ajit S Narang; Divyakant Desai; Sherif Badawy
Journal:  Pharm Res       Date:  2012-06-16       Impact factor: 4.200

3.  Recent trends in product development and regulatory issues on impurities in active pharmaceutical ingredient (API) and drug products. Part 1: Predicting degradation related impurities and impurity considerations for pharmaceutical dosage forms.

Authors:  Karen M Alsante; Kim Huynh-Ba; Steven W Baertschi; Robert A Reed; Margaret S Landis; Mark H Kleinman; Christopher Foti; Venkatramana M Rao; Paul Meers; Andreas Abend; Daniel W Reynolds; Biren K Joshi
Journal:  AAPS PharmSciTech       Date:  2013-11-27       Impact factor: 3.246

Review 4.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

5.  Development of a stable low-dose aglycosylated antibody formulation to minimize protein loss during intravenous administration.

Authors:  Sorina Morar-Mitrica; Manasi Puri; Alexandra Beumer Sassi; Joshua Fuller; Ping Hu; George Crotts; Douglas Nesta
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 6.  Importance and globalization status of good manufacturing practice (GMP) requirements for pharmaceutical excipients.

Authors:  Abubaker Abdellah; Mohamed Ibrahim Noordin; Wan Azman Wan Ismail
Journal:  Saudi Pharm J       Date:  2013-06-26       Impact factor: 4.330

7.  Low-temperature NMR characterization of reaction of sodium pyruvate with hydrogen peroxide.

Authors:  Christopher Asmus; Olivier Mozziconacci; Christian Schöneich
Journal:  J Phys Chem A       Date:  2015-01-29       Impact factor: 2.781

8.  Lactose contaminant as steroid degradation enhancer.

Authors:  Florentine Nieuwmeyer; Kees van der Voort Maarschalk; Herman Vromans
Journal:  Pharm Res       Date:  2008-08-01       Impact factor: 4.200

9.  Effect of polysorbate 80 concentration on thermal and photostability of a monoclonal antibody.

Authors:  Meera Agarkhed; Courtney O'Dell; Ming-Ching Hsieh; Jingming Zhang; Joel Goldstein; Arvind Srivastava
Journal:  AAPS PharmSciTech       Date:  2012-11-14       Impact factor: 3.246

10.  Effect of EDTA and methionine on preventing loss of viscosity of cellulose-based topical gel.

Authors:  Junyan A Ji; Erika Ingham; John Y Wang
Journal:  AAPS PharmSciTech       Date:  2009-05-21       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.